Automated Color-Coding of Lesion Changes in Contrast-Enhanced 3D T1-Weighted Sequences for MRI Follow-up of Brain Metastases.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
02 2022
Historique:
received: 11 04 2021
accepted: 06 10 2021
pubmed: 8 1 2022
medline: 11 3 2022
entrez: 7 1 2022
Statut: ppublish

Résumé

MR imaging is the technique of choice for follow-up of patients with brain metastases, yet the radiologic assessment is often tedious and error-prone, especially in examinations with multiple metastases or subtle changes. This study aimed to determine whether using automated color-coding improves the radiologic assessment of brain metastases compared with conventional reading. One hundred twenty-one pairs of follow-up examinations of patients with brain metastases were assessed. Two radiologists determined the presence of progression, regression, mixed changes, or stable disease between the follow-up examinations and indicated subjective diagnostic certainty regarding their decisions in a conventional reading and a second reading using automated color-coding after an interval of 8 weeks. The rate of correctly classified diagnoses was higher (91.3%, 221/242, versus 74.0%, 179/242, Compared with the conventional reading, automated color-coding of lesion changes in follow-up examinations of patients with brain metastases significantly increased the rate of correct diagnoses and resulted in higher diagnostic certainty.

Sections du résumé

BACKGROUND AND PURPOSE
MR imaging is the technique of choice for follow-up of patients with brain metastases, yet the radiologic assessment is often tedious and error-prone, especially in examinations with multiple metastases or subtle changes. This study aimed to determine whether using automated color-coding improves the radiologic assessment of brain metastases compared with conventional reading.
MATERIALS AND METHODS
One hundred twenty-one pairs of follow-up examinations of patients with brain metastases were assessed. Two radiologists determined the presence of progression, regression, mixed changes, or stable disease between the follow-up examinations and indicated subjective diagnostic certainty regarding their decisions in a conventional reading and a second reading using automated color-coding after an interval of 8 weeks.
RESULTS
The rate of correctly classified diagnoses was higher (91.3%, 221/242, versus 74.0%, 179/242,
CONCLUSIONS
Compared with the conventional reading, automated color-coding of lesion changes in follow-up examinations of patients with brain metastases significantly increased the rate of correct diagnoses and resulted in higher diagnostic certainty.

Identifiants

pubmed: 34992128
pii: ajnr.A7380
doi: 10.3174/ajnr.A7380
pmc: PMC8985679
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

188-194

Informations de copyright

© 2022 by American Journal of Neuroradiology.

Références

Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):593-601
pubmed: 29282517
Radiology. 2019 Nov;293(2):436-440
pubmed: 31573399
Can Assoc Radiol J. 2018 May;69(2):120-135
pubmed: 29655580
J Med Imaging Radiat Oncol. 2018 Dec;62(6):747-757
pubmed: 30198628
Br J Radiol. 2019 Jul;92(1099):20190043
pubmed: 30933540
J Clin Oncol. 2004 Jul 15;22(14):2865-72
pubmed: 15254054
J Am Coll Radiol. 2015 Jul;12(7):664-9
pubmed: 25972250
Br J Radiol. 2019 Mar;92(1095):20180845
pubmed: 30457880
Neurol Clin. 2003 Feb;21(1):1-23, vii
pubmed: 12690643
AJNR Am J Neuroradiol. 2018 Jul;39(7):1226-1232
pubmed: 29880479
Invest Radiol. 1990 Feb;25(2):133-40
pubmed: 2312249
Eur Radiol. 2019 Dec;29(12):7047-7054
pubmed: 31201526
Nat Rev Dis Primers. 2019 Jan 17;5(1):5
pubmed: 30655533
Eur Radiol. 2020 Jun;30(6):3576-3584
pubmed: 32064565
Handb Clin Neurol. 2018;149:89-112
pubmed: 29307364
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:4893-6
pubmed: 22255435
NMR Biomed. 2016 Jul;29(7):882-9
pubmed: 27120035
Neuro Oncol. 2020 Jun 9;22(6):757-772
pubmed: 32048719
Oncology (Williston Park). 1999 Jul;13(7):941-54, 957-61; discussion 961-2, 9
pubmed: 10442342
J Neurol. 2002 Oct;249(10):1357-69
pubmed: 12382150
AJNR Am J Neuroradiol. 2017 May;38(5):923-927
pubmed: 28364006
Eur Radiol. 2019 Jan;29(1):124-132
pubmed: 29943184
J Magn Reson Imaging. 2020 Oct;52(4):1197-1206
pubmed: 32246803
Lancet Oncol. 2015 Jun;16(6):e270-8
pubmed: 26065612
AJNR Am J Neuroradiol. 1990 Jul-Aug;11(4):785-91
pubmed: 2114769
AJR Am J Roentgenol. 2018 Apr;210(4):799-806
pubmed: 29446673
AJNR Am J Neuroradiol. 2019 Oct;40(10):1624-1629
pubmed: 31515214
J Magn Reson Imaging. 2020 Jan;51(1):175-182
pubmed: 31050074

Auteurs

D Zopfs (D)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany David.zopfs@uk-koeln.de.

K Laukamp (K)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

R Reimer (R)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

N Grosse Hokamp (N)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

C Kabbasch (C)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

J Borggrefe (J)

Department of Radiology (J.B.), Neuroradiology and Nuclear Medicine, Johannes Wesling University Hospital, Ruhr University Bochum, Bochum, Germany.

L Pennig (L)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

A C Bunck (AC)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

M Schlamann (M)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

S Lennartz (S)

From the Institute for Diagnostic and Interventional Radiology (D.Z., K.L., R.R., N.G.H., C.K., L.P., A.C.B., M.S., S.L.), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH